IDOSE TREX Trademark

Trademark Overview

On Wednesday, July 16, 2025, a trademark application was filed for IDOSE TREX with the United States Patent and Trademark Office. The USPTO has given the IDOSE TREX trademark a serial number of 99286839. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 16, 2025. This trademark is owned by Glaukos Corporation. The IDOSE TREX trademark is filed in the Medical Instrument Products category with the following description:

Intraocular drug delivery system comprising of a micro-stent intended for implantation into the eye for use in the treatment of diseases of the eye
idose trex

General Information

Serial Number99286839
Word MarkIDOSE TREX
Filing DateWednesday, July 16, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, July 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesIntraocular drug delivery system comprising of a micro-stent intended for implantation into the eye for use in the treatment of diseases of the eye

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, July 16, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaukos Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656

Trademark Events

Event DateEvent Description
Wednesday, July 16, 2025NEW APPLICATION ENTERED
Wednesday, July 16, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

trex idose intended implantation treatment diseases stent micro drug delivery system comprising